Automated Author ProfileUeda, Mitsuharu
Ueda, Mitsuharu
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 4.1 (sum of 9 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Hereditary transthyretin amyloidosis with cardiomyopathy and polyneuropathy associated with a novel pathogenic TTR Tyr105His (p.Tyr125His) mutation
Authors
- Nakamori, Masahiro ;
- Tachiyama, Keisuke ;
- Matsumura, Naoe ;
- Hironaka, Akemi ;
- Muraoka, Yuji ;
- Kitagawa, Toshiro ;
- Tasaki, Masayoshi ;
- Yamakawa, Shiori ;
- Ueda, Mitsuharu ;
- Maruyama, Hirofumi
Hereditary transthyretin amyloidosis with cardiomyopathy and polyneuropathy associated with a novel pathogenic TTR Tyr105His (p.Tyr125His) mutation
Authors
- Nakamori, Masahiro ;
- Tachiyama, Keisuke ;
- Matsumura, Naoe ;
- Hironaka, Akemi ;
- Muraoka, Yuji ;
- Kitagawa, Toshiro ;
- Tasaki, Masayoshi ;
- Yamakawa, Shiori ;
- Ueda, Mitsuharu ;
- Maruyama, Hirofumi
A high incidence of valvular involvement of amyloid in the setting of aortic stenosis (AS) has been reported. Amyloid derived from ApoAI (AApoAI) can form local amyloid deposits in the aortic valve. Although a high prevalence of concomitant severe AS and cardiac transthyretin-type amyloidosis (ATTR) has been reported, the prevalence of valvular involvement by ATTR and AApoAI is unclear. Using immunostaining and mass spectrometry, we analysed amyloid proteins in 97 aortic valves removed for valve replacement due to AS at Kyoto Prefectural University of Medicine between 2014 and 2021. Clinical information was also reviewed. Amyloid deposits were found in 44 cases (45%), of which 30 cases (68%) involved ATTR and 33 cases (75%) AApoAI. Statistical analysis showed significantly lower age and E/e′ among amyloid-positive cases compared with amyloid-negative cases and significantly lower brain natriuretic peptide, higher fractional shortening, and higher left ventricular ejection fraction among ATTR-positive cases compared with ATTR-negative cases. Seven recent patients underwent bone scintigraphy and ATTR cardiomyopathy was observed in only one case. AS symptoms can manifest earlier in patients with amyloid or ATTR deposition in the aortic valve than in patients without such deposition, even though left ventricular function is preserved.
Authors
- Honda, Kohei ;
- Tasaki, Masayoshi ;
- Yamano, Tetsuhiro ;
- Ueda, Mitsuharu ;
- Naiki, Hironobu ;
- Tanaka, Noriyuki ;
- Morinaga, Yukiko ;
- Miyagawa-Hayashino, Aya
A high incidence of valvular involvement of amyloid in the setting of aortic stenosis (AS) has been reported. Amyloid derived from ApoAI (AApoAI) can form local amyloid deposits in the aortic valve. Although a high prevalence of concomitant severe AS and cardiac transthyretin-type amyloidosis (ATTR) has been reported, the prevalence of valvular involvement by ATTR and AApoAI is unclear. Using immunostaining and mass spectrometry, we analysed amyloid proteins in 97 aortic valves removed for valve replacement due to AS at Kyoto Prefectural University of Medicine between 2014 and 2021. Clinical information was also reviewed. Amyloid deposits were found in 44 cases (45%), of which 30 cases (68%) involved ATTR and 33 cases (75%) AApoAI. Statistical analysis showed significantly lower age and E/e′ among amyloid-positive cases compared with amyloid-negative cases and significantly lower brain natriuretic peptide, higher fractional shortening, and higher left ventricular ejection fraction among ATTR-positive cases compared with ATTR-negative cases. Seven recent patients underwent bone scintigraphy and ATTR cardiomyopathy was observed in only one case. AS symptoms can manifest earlier in patients with amyloid or ATTR deposition in the aortic valve than in patients without such deposition, even though left ventricular function is preserved.
Authors
- Honda, Kohei ;
- Tasaki, Masayoshi ;
- Yamano, Tetsuhiro ;
- Ueda, Mitsuharu ;
- Naiki, Hironobu ;
- Tanaka, Noriyuki ;
- Morinaga, Yukiko ;
- Miyagawa-Hayashino, Aya
A high incidence of valvular involvement of amyloid in the setting of aortic stenosis (AS) has been reported. Amyloid derived from ApoAI (AApoAI) can form local amyloid deposits in the aortic valve. Although a high prevalence of concomitant severe AS and cardiac transthyretin-type amyloidosis (ATTR) has been reported, the prevalence of valvular involvement by ATTR and AApoAI is unclear. Using immunostaining and mass spectrometry, we analysed amyloid proteins in 97 aortic valves removed for valve replacement due to AS at Kyoto Prefectural University of Medicine between 2014 and 2021. Clinical information was also reviewed. Amyloid deposits were found in 44 cases (45%), of which 30 cases (68%) involved ATTR and 33 cases (75%) AApoAI. Statistical analysis showed significantly lower age and E/e′ among amyloid-positive cases compared with amyloid-negative cases and significantly lower brain natriuretic peptide, higher fractional shortening, and higher left ventricular ejection fraction among ATTR-positive cases compared with ATTR-negative cases. Seven recent patients underwent bone scintigraphy and ATTR cardiomyopathy was observed in only one case. AS symptoms can manifest earlier in patients with amyloid or ATTR deposition in the aortic valve than in patients without such deposition, even though left ventricular function is preserved.
Authors
- Honda, Kohei ;
- Tasaki, Masayoshi ;
- Yamano, Tetsuhiro ;
- Ueda, Mitsuharu ;
- Naiki, Hironobu ;
- Tanaka, Noriyuki ;
- Morinaga, Yukiko ;
- Miyagawa-Hayashino, Aya
Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis
Authors
- Tasaki, Masayoshi ;
- Misumi, Yohei ;
- Nomura, Toshiya ;
- Kamba, Tomomi ;
- Ueda, Mitsuharu
Fibrinogen A α-chain amyloidosis associated with a rare frameshift pathogenic variant p.Arg547GlyfsTer21
Authors
- Tasaki, Masayoshi ;
- Nomura, Toshiya ;
- Uchiyama, Koichi ;
- Misumi, Yohei ;
- Nakahara, Keiichi ;
- Oyama, Yuzo ;
- Uesugi, Noriko ;
- Ueda, Mitsuharu
Detection of semenogelin 1 amyloidosis through immunohistochemical staining with novel antiserum developed based on mass spectrometric peptide mapping analysis
Authors
- Tasaki, Masayoshi ;
- Misumi, Yohei ;
- Nomura, Toshiya ;
- Kamba, Tomomi ;
- Ueda, Mitsuharu
Fibrinogen A α-chain amyloidosis associated with a rare frameshift pathogenic variant p.Arg547GlyfsTer21
Authors
- Tasaki, Masayoshi ;
- Nomura, Toshiya ;
- Uchiyama, Koichi ;
- Misumi, Yohei ;
- Nakahara, Keiichi ;
- Oyama, Yuzo ;
- Uesugi, Noriko ;
- Ueda, Mitsuharu